Qld biotech fund calls for proposals
14 November, 2002 by Pete YoungThe $100 million Queensland BioCapital Fund, whose formation was announced five months ago by the State government, is finally swinging its doors open for business.
We're publishing (and perishing) as fast as we can
13 November, 2002 by Graeme O'NeillFiddle with an old recipe and you may get an unpalatable, but not always unpredictable result.
INTERVIEW: Taking care of business
12 November, 2002 by Melissa TrudingerResearch institutes looking at ways to commercialise their intellectual property could do worse than examine the model used by Melbourne's Austin Research Institute.
NHMRC grants stick to the big smoke
12 November, 2002 by Pete YoungThe latest round of NHMRC funding grants shows Queensland's boast of being the most decentralised state does not extend to medical research.
Autogen, Antisense to raise $10m in separate placements
07 November, 2002 by Melissa TrudingerTwo Melbourne companies, Autogen and Antisense Therapeutics, have launched fully underwritten share placements to raise more than $10 million between them in capital.
IDG stable expands with new life science acquisition
06 November, 2002 by Staff WritersIDG Communications, publisher of Australian Biotechnology News, this week acquired two titles -- Today's Life Science and Lab News -- from Vertical Markets.
NHMRC fellowships to spur commercialisation
05 November, 2002 by Iain ScottThe National Health and Medical Research Council has awarded five new Industry Fellowships to encourage researchers to learn more about the commercial aspects of R&D.
Khan to raise Biota takover offer
31 October, 2002 by Pete YoungAn embarrassing oversight has forced a listed company controlled by self-styled "corporate rationaliser" Farooq Khan to lift its takeover offer for biotech Biota Holdings.
Microarrays and sequencers: Expressions in array technology
31 October, 2002 by Melissa TrudingerMicroarray technology is now a major tool available to the geneticist. The technology allows researchers to look at the expression of a vast array of genes simultaneously, and myriad applications have been found in the last few years. But deciding on the best microarray system for the needs of the research is a difficult task, with several choices available.
$150m funding announced in NHMRC project grants
30 October, 2002 by Graeme O'NeillThe annual competition for research grants from the National Health and Medical Research Council (NHMRC) has been fought and and won -- and 406 projects have won the prestigious, peer-reviewed right to share in this year's funding pool of $150 million.
Business development feature: Do you go with the pros?
30 October, 2002 by Melissa TrudingerGood ideas and good science are not the only things a biotechnology company needs to get itself off the ground. In order to raise the amount of capital needed to take a company from being a mere glint in the eye of a scientist to a successful, publicly listed biotechnology company requires a lot of behind the scenes planning and strategy, business acumen, and networking.
WA research centre appeals to philanthropy
28 October, 2002 by Pete YoungA young cooperative research institute in Western Australia is hoping wealthy philanthropists will help it plug a funding gap.
Closer Sino-Australian biotech ties tipped
25 October, 2002 by Melissa TrudingerA conference in China attended by two Australian scientists may lead to closer links between the two countries.
NSW incubator appoints associate director
23 October, 2002 by Iain ScottThe NSW government's new BioFirst biotechnology incubator is on track for its February 2003 opening and has made named a high-level tech transfer specialist as its associate director.
Khan attacks Biota board performance, pay
23 October, 2002 by Pete YoungThe performance and pay of Biota Holdings' directors have been attacked by the drug discovery company's largest shareholder.
